Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 41: 1159-1163, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barto, R.
Right arrow Articles by Netelenbos, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barto, R.
Right arrow Articles by Netelenbos, J. C.

Clinical Chemistry, Vol 41, 1159-1163, Copyright © 1995 by American Association for Clinical Chemistry

Sensitive method for analysis of strontium in human and animal plasma by graphite furnace atomic absorption spectrophotometry

R Barto, AJ Sips, WJ van der Vijgh and JC Netelenbos
Clinical Research Laboratory of Internal Medicine, Free University Hospital, Amsterdam, The Netherlands.

For long-term pharmacokinetic studies in humans as well as in experimental animals, an analysis of strontium (Sr) with a low detection limit and high sensitivity is necessary. The data presented here describe the optimization of the furnace program and sample handling for measuring Sr in plasma by using graphite furnace atomic absorption spectrophotometry. The method was validated and applied to studies on the pharmacokinetics of SrCl2 in humans and rats. Calibration curves were linear up to 57.1 nmol/L. The limit of detection and lower limit of quantification were 0.21 and 0.57 nmol/L, respectively. Reciprocal sensitivity was 0.53 nmol/L Sr at A = 0.0044. The intraassay precision was 2.2%, 1.5%, and 1.1% (n = 6) at 4.57, 22.7, and 49.2 nmol/L Sr, respectively. At these concentrations, the interassay precision and recovery were 0.7%, 1.5%, and 1.8% and 100.4%, 99.1%, and 100.6% (n = 12), respectively. The endogenous Sr concentration in human plasma samples was 0.27 +/- 0.07 mumol/L (n = 18). Pharmacokinetic studies in a human volunteer and in rats demonstrated that this procedure was suited for measuring low Sr concentrations and was applicable to small sample volumes.


The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
M. Dijkgraaf-ten Bolscher, J. C. Netelenbos, R. Barto, and W. J.F. van der Vijgh
Strontium as a Marker for Intestinal Calcium Absorption: The Stimulatory Effect of Calcitriol
Clin. Chem., February 1, 2000; 46(2): 248 - 251.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. C. D'Haese, G. F. Van Landeghem, L. V. Lamberts, V. A. Bekaert, I. Schrooten, and M. E. De Broe
Measurement of strontium in serum, urine, bone, and soft tissues by Zeeman atomic absorption spectrometry
Clin. Chem., January 1, 1997; 43(1): 121 - 128.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.